Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donepezil and Memantine in Moderate to Severe Alzheimer's Disease

NCT00866060 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT00866060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00866060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donepezil and Memantine in Moderate to Severe Alzheimer's Disease
Lead sponsor
King's College London
Phase
Phase 4
Overall status
Unknown status
Start date
February 29, 2008
Completion date
June 30, 2013
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe alzheimer's disease